Disentangling such a specific signature of intestinal microbiota involved in insulin resistance shifts might help to apply approaches aiming to better predict loss of insulin sensitivity and design targeted microbiota-based interventions in obese humans. The gene discussed is INS; the disease is Insulin resistance.